Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck

被引：42

作者：

Keam, B. ^{[1
]}

Machiels, J-P ^{[2
]}

Kim, H. R. ^{[3
]}

Licitra, L. ^{[4
,5
]}

Golusinski, W. ^{[6
]}

Gregoire, V ^{[7
]}

Lee, Y. G. ^{[8
]}

Belka, C. ^{[9
]}

Guo, Y. ^{[10
]}

Rajappa, S. J. ^{[11
]}

Tahara, M. ^{[12
]}

Azrif, M. ^{[13
]}

Ang, M. K. ^{[14
]}

Yang, M-H ^{[15
]}

Wang, C-H ^{[16
,17
]}

Ng, Q. S. ^{[18
]}

Zamaniah, W. I. Wan ^{[19
]}

Kiyota, N. ^{[20
]}

Babu, S. ^{[21
]}

Yang, K. ^{[22
]}

Curigliano, G. ^{[23
,24
]}

Peters, S. ^{[25
]}

Kim, T. W. ^{[26
]}

Yoshino, T. ^{[27
]}

Pentheroudakis, G. ^{[28
]}

机构：

[1] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea

[2] Clin Univ St Luc, Serv Oncol Med, Inst Roi Albert 2, Brussels, Belgium

[3] Yonsei Univ, Yonsei Canc Ctr, Dept Internal Med, Div Med Oncol,Coll Med, Seoul, South Korea

[4] Fdn IRCCS Ist Nazl Tumori, Head & Neck Canc Med Oncol Dept, Milan, Italy

[5] Univ Milan, Milan, Italy

[6] Poznan Univ Med Sci, Greater Poland Canc Ctr, Dept Head & Neck Surg, Poznan, Poland

[7] Ctr Leon Berard, Dept Radiat Oncol, Lyon, France

[8] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Hematol & Med Oncol,Sch Med, Seoul, South Korea

[9] LMU Hosp, Dept Radiat Oncol, Munich, Germany

[10] Tongji Univ, Shanghai East Hosp, Dept Med Oncol, Sch Med, Shanghai, Peoples R China

[11] Basavatarakam Indo Amer Canc Hosp & Res Inst, Med Oncol, Hyderabad, India

[12] Natl Canc Ctr Hosp East, Dept Head & Neck Med Oncol, Chiba, Japan

[13] Prince Court Med Ctr, Clin Oncol, Kuala Lumpur, Malaysia

[14] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore

[15] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan

[16] Keelung Chang Gung Mem Hosp, Dept Internal Med, Div Hematooncol, Taoyuan, Taiwan

[17] Chang Gung Univ, Coll Med, Taoyuan, Taiwan

[18] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore

[19] Univ Malaya, Fac Med, Clin Oncol Unit, Kuala Lumpur, Malaysia

[20] Kobe Univ Hosp, Canc Ctr, Oncol Hematol, Kobe, Hyogo, Japan

[21] Kidwai Mem Inst Oncol, Dept Med Oncol, Bangalore, Karnataka, India

[22] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Clin Oncol, Wuhan, Peoples R China

[23] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy

[24] IRCCS, Ist Europeo Oncol, Milan, Italy

[25] Ctr Hosp Univ Vaudois CHUV, Dept Oncol, Lausanne, Switzerland

[26] Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea

[27] Natl Canc Ctr East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan

[28] ESMO, Lugano, Switzerland

来源：

ESMO OPEN | 2021年 / 6卷 / 06期

关键词：

ESMO; guidelines; head and neck; Pan-Asian; squamous cell carcinoma; treatment; CHEMOTHERAPY PLUS CETUXIMAB; QUALITY-OF-LIFE; INVESTIGATORS CHOICE; WEEKLY CISPLATIN; OPEN-LABEL; RECURRENT; CANCER; TRENDS; NIVOLUMAB; THERAPY;

D O I：

10.1016/j.esmoop.2021.100309

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of squamous cell carcinoma (SCC) of the oral cavity, larynx, oropharynx and hypopharynx was published in 2020. It was therefore decided by both the ESMO and the Korean Society of Medical Oncology (KSMO) to convene a special, virtual guidelines meeting in July 2021 to adapt the ESMO 2020 guidelines to consider the potential ethnic differences associated with the treatment of SCCs of the head and neck (SCCHN) in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with SCCHN (excluding nasopharyngeal carcinomas) representing the oncological societies of Korea (KSMO), China (CSCO), India (ISMPO), Japan (JSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence and was independent of the current treatment practices and drug access restrictions in the different Asian countries. The latter was discussed when appropriate. This manuscript provides a series of expert recommendations (Clinical Practice Guidelines) which can be used to provide guidance to health care providers and clinicians for the optimisation of the diagnosis, treatment and management of patients with SCC of the oral cavity, larynx, oropharynx and hypopharynx across Asia.

引用

页数：12

共 50 条

[31] Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Glynne-Jones, R.
Nilsson, P. J.
Aschele, C.
Goh, V.
Peiffert, D.
Cervantes, A.
Arnold, D.
ANNALS OF ONCOLOGY, 2014, 25 : 10 - 20
[32] Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up
Waddell, T.
Verheij, M.
Allum, W.
Cunningham, D.
Cervantes, A.
Arnold, D.
EJSO, 2014, 40 (05): : 584 - 591
[33] Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up
Glynne-Jones, Robert
Nilsson, Per J.
Aschele, Carlo
Goh, Vicky
Peiffert, Didier
Cervantes, Andres
Arnold, Dirk
RADIOTHERAPY AND ONCOLOGY, 2014, 111 (03) : 330 - 339
[34] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer
Im, S. -A.
Gennari, A.
Park, Y. H.
Kim, J. H.
Jiang, Z. -F.
Gupta, S.
Fadjari, T. H.
Tamura, K.
Mastura, M. Y.
Abesamis-Tiambeng, M. L. T.
Lim, E. H.
Lin, C. -H.
Sookprasert, A.
Parinyanitikul, N.
Tseng, L. -M.
Lee, S. -C.
Caguioa, P.
Singh, M.
Naito, Y.
Hukom, R. A.
Smruti, B. K.
Wang, S. -S.
Kim, S. B.
Lee, K. -H.
Ahn, H. K.
Peters, S.
Kim, T. W.
Yoshino, T.
Pentheroudakis, G.
Curigliano, G.
Harbeck, N.
ESMO OPEN, 2023, 8 (03)
[35] Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dummer, R.
Hauschild, A.
Guggenheim, M.
Jost, L.
Pentheroudakis, G.
ANNALS OF ONCOLOGY, 2010, 21 : v194 - v197
[36] Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Bossi, P.
Chan, A. T.
Licitra, L.
Trama, A.
Orlandi, E.
Hui, E. P.
Halamkova, J.
Mattheis, S.
Baujat, B.
Hardillo, J.
Smeele, L.
van Herpen, C.
Castro, A.
Machiels, J-P
ANNALS OF ONCOLOGY, 2021, 32 (04) : 452 - 465
[37] Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Verslype, C.
Rosmorduc, O.
Rougier, P.
ANNALS OF ONCOLOGY, 2012, 23 : 41 - 48
[38] Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Powles, T.
Albiges, L.
Bex, A.
Comperat, E.
Gruenwald, V.
Kanesvaran, R.
Kitamura, H.
McKay, R.
Porta, C.
Procopio, G.
Schmidinger, M.
Suarez, C.
Teoh, J.
de Velasco, G.
Young, M.
Gillessen, S.
ANNALS OF ONCOLOGY, 2024, 35 (08) : 692 - 706
[39] Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Pacini, F.
Castagna, M. G.
Brilli, L.
Pentheroudakis, G.
ANNALS OF ONCOLOGY, 2012, 23 : 110 - 119
[40] Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Haie-Meder, C.
Morice, P.
Castiglione, M.
ANNALS OF ONCOLOGY, 2010, 21 : v37 - v40

← 1 2 3 4 5 →